CIK 0001267565
- Large accelerated filer
COLLEGIUM PHARMACEUTICAL, INC
Sign in to watch- Ticker
- COLL
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- VA
- Entity type
- Operating
- Phone
- +1 781-713-3699
- Business address
- 100 TECHNOLOGY CENTER DRIVE, STOUGHTON, MA, 02072
- Former names
- COLLEGIUM PHARMACEUTICAL INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2017-12-14 | Brannelly Paul Executive Vice President & CFO | Gift | −2,000 | 108,803 | ||
| 2017-12-08 | Hirsch David Director | Sale | −980,350 | $17.34 | $17.0M | 2,276,222 |
| 2017-12-08 | Hirsch David Director | Sale | −19,650 | $17.34 | $341K | 45,620 |
| 2017-12-08 | Longitude Capital Partners, LLC 10% owner | Sale | −980,350 | $17.34 | $17.0M | 2,276,222 |
| 2017-12-08 | Longitude Capital Partners, LLC 10% owner | Sale | −19,650 | $17.34 | $341K | 45,620 |
| 2017-12-05 | Freund John Gordon Director | Other disposition | −800,000 | 2,149,916 | ||
| 2017-12-05 | Freund John Gordon Director | Other acquisition | +11,715 | 11,715 | ||
| 2017-12-05 | KANEKO YASUNORI 10% owner | Other disposition | −800,000 | 2,149,916 | ||
| 2017-12-05 | KANEKO YASUNORI 10% owner | Other acquisition | +270 | 270 | ||
| 2017-12-05 | Skyline Venture Partners V LP 10% owner | Other disposition | −800,000 | 2,149,916 | ||
| 2017-11-21 | Fleming Alison B Chief Technology Officer | Option exercise | +572 | $0.28 | $160 | 26,295 |
| 2017-11-21 | Fleming Alison B Chief Technology Officer | Sale | −572 | $19.00 | $11K | 25,723 |
| 2017-11-21 | Fleming Alison B Chief Technology Officer | Option exercise · Stock option (right to purchase) | −572 | 3,917 | ||
| 2017-11-17 | Fleming Alison B Chief Technology Officer | Option exercise | +1,950 | $0.28 | $546 | 28,513 |
| 2017-11-17 | Fleming Alison B Chief Technology Officer | Sale | −1,950 | $17.00 | $33K | 26,563 |
| 2017-11-17 | Fleming Alison B Chief Technology Officer | Option exercise | +1,239 | $0.28 | $347 | 27,802 |
| 2017-11-17 | Fleming Alison B Chief Technology Officer | Sale | −1,239 | $17.00 | $21K | 26,563 |
| 2017-11-17 | Fleming Alison B Chief Technology Officer | Sale | −840 | $17.00 | $14K | 25,723 |
| 2017-11-17 | Fleming Alison B Chief Technology Officer | Option exercise · Stock option (right to purchase) | −1,950 | 4,225 | ||
| 2017-11-17 | Fleming Alison B Chief Technology Officer | Option exercise · Stock option (right to purchase) | −1,239 | 4,489 |
Page 34 of 41 · 811 trades